Conclusion TB-500 is a synthetic peptide based on Thymosin Beta-4 that has been investigated for its possible interactions with actin, vascular remodeling, inflammation pathways, wound models, and cardiac systems
The administration of BPC157 was well tolerated by all dogs, and no visual signs of toxicity were observed, which was consistent with our previous safety evaluation studies
Preparation and characterization of liposomal coenzyme Q10 for in vivo topical application
No objective vision measurements (visual acuity, visual field, OCT imaging)
For full protocol detail, including reconstitution volumes, post-reconstitution storage windows, and research administration schedules, see our full BPC-157 + TB-500 dosing protocol